Cancer has emerged over the last decades as one of the deadliest diseases in the world.
Among the most commonly used techniques (ie surgery, immunotherapy, radiotherapy or …

Ruthenium (II)-based coordination complexes have emerged as photosensitizers (PSs) for
photodynamic therapy (PDT) in oncology as well as antimicrobial indications and have great …

Tumor metastases are considered the leading cause of cancer-associated deaths. While
clinically applied drugs have demonstrated to efficiently remove the primary tumor …

Effective photosensitizers are of particular importance for the widespread clinical utilization
of phototherapy. However, conventional photosensitizers are usually plagued by short …

Selective activation of Pt (IV) prodrugs within tumors is particularly attractive because of their
low damage to normal tissues. However, current common activation via chemical …

Ru (II) polypyridine complexes have attracted much attention as anticancer agents because
of their unique photophysical, photochemical, and biological properties. Despite their …

Metal complexes have shown promise as photosensitizers for cancer diagnosis and
therapeutics. However, the vast majority of metal photosensitizers are not ideal and …

Photocatalysis has emerged as a powerful synthetic tool to facilitate redox reactions with the
target of creating stable and tunable photocatalytic materials. A class of recyclable …

Ru (II) polypyridyl complexes are compounds of great interest in cancer therapy due to their
unique photophysical, photochemical, and biological properties. For effective treatment, they …

Photodynamic therapy (PDT) is emerging as a significant complementary or alternative
approach for cancer treatment. PDT drugs act as photosensitisers, which upon using …